The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Brexpiprazole Market Research Report 2025
Synopsis
It is an atypical antipsychotic. It is a dopamine D2 receptor partial agonist and has been described as a "serotonin–dopamine activity modulator" (SDAM)
Global Brexpiprazole market is projected to reach US$ 6163.1 million in 2029, increasing from US$ 1720 million in 2022, with the CAGR of 20.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Brexpiprazole market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Brexpiprazole market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Intas Pharma
Zydus Lifesciences
Ajanta Pharma
Teva
Sandoz
Otsuka Pharma
Lundbeck
Segment by Type
1Mg
2Mg
Segment by Application
Schizophrenia
Major Depressive Disorder
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Brexpiprazole report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
It is an atypical antipsychotic. It is a dopamine D2 receptor partial agonist and has been described as a "serotonin–dopamine activity modulator" (SDAM)
Global Brexpiprazole market is projected to reach US$ 6163.1 million in 2029, increasing from US$ 1720 million in 2022, with the CAGR of 20.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Brexpiprazole market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Brexpiprazole market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Intas Pharma
Zydus Lifesciences
Ajanta Pharma
Teva
Sandoz
Otsuka Pharma
Lundbeck
Segment by Type
1Mg
2Mg
Segment by Application
Schizophrenia
Major Depressive Disorder
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Brexpiprazole report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Brexpiprazole Market Overview
1.1 Product Overview and Scope of Brexpiprazole
1.2 Brexpiprazole Segment by Type
1.2.1 Global Brexpiprazole Market Value Comparison by Type (2023-2029)
1.2.2 1Mg
1.2.3 2Mg
1.3 Brexpiprazole Segment by Application
1.3.1 Global Brexpiprazole Market Value by Application: (2023-2029)
1.3.2 Schizophrenia
1.3.3 Major Depressive Disorder
1.4 Global Brexpiprazole Market Size Estimates and Forecasts
1.4.1 Global Brexpiprazole Revenue 2018-2029
1.4.2 Global Brexpiprazole Sales 2018-2029
1.4.3 Global Brexpiprazole Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Brexpiprazole Market Competition by Manufacturers
2.1 Global Brexpiprazole Sales Market Share by Manufacturers (2018-2023)
2.2 Global Brexpiprazole Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Brexpiprazole Average Price by Manufacturers (2018-2023)
2.4 Global Brexpiprazole Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Brexpiprazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Brexpiprazole, Product Type & Application
2.7 Brexpiprazole Market Competitive Situation and Trends
2.7.1 Brexpiprazole Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Brexpiprazole Players Market Share by Revenue
2.7.3 Global Brexpiprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Brexpiprazole Retrospective Market Scenario by Region
3.1 Global Brexpiprazole Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Brexpiprazole Global Brexpiprazole Sales by Region: 2018-2029
3.2.1 Global Brexpiprazole Sales by Region: 2018-2023
3.2.2 Global Brexpiprazole Sales by Region: 2024-2029
3.3 Global Brexpiprazole Global Brexpiprazole Revenue by Region: 2018-2029
3.3.1 Global Brexpiprazole Revenue by Region: 2018-2023
3.3.2 Global Brexpiprazole Revenue by Region: 2024-2029
3.4 North America Brexpiprazole Market Facts & Figures by Country
3.4.1 North America Brexpiprazole Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Brexpiprazole Sales by Country (2018-2029)
3.4.3 North America Brexpiprazole Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Brexpiprazole Market Facts & Figures by Country
3.5.1 Europe Brexpiprazole Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Brexpiprazole Sales by Country (2018-2029)
3.5.3 Europe Brexpiprazole Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Brexpiprazole Market Facts & Figures by Country
3.6.1 Asia Pacific Brexpiprazole Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Brexpiprazole Sales by Country (2018-2029)
3.6.3 Asia Pacific Brexpiprazole Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Brexpiprazole Market Facts & Figures by Country
3.7.1 Latin America Brexpiprazole Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Brexpiprazole Sales by Country (2018-2029)
3.7.3 Latin America Brexpiprazole Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Brexpiprazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Brexpiprazole Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Brexpiprazole Sales by Country (2018-2029)
3.8.3 Middle East and Africa Brexpiprazole Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Brexpiprazole Sales by Type (2018-2029)
4.1.1 Global Brexpiprazole Sales by Type (2018-2023)
4.1.2 Global Brexpiprazole Sales by Type (2024-2029)
4.1.3 Global Brexpiprazole Sales Market Share by Type (2018-2029)
4.2 Global Brexpiprazole Revenue by Type (2018-2029)
4.2.1 Global Brexpiprazole Revenue by Type (2018-2023)
4.2.2 Global Brexpiprazole Revenue by Type (2024-2029)
4.2.3 Global Brexpiprazole Revenue Market Share by Type (2018-2029)
4.3 Global Brexpiprazole Price by Type (2018-2029)
5 Segment by Application
5.1 Global Brexpiprazole Sales by Application (2018-2029)
5.1.1 Global Brexpiprazole Sales by Application (2018-2023)
5.1.2 Global Brexpiprazole Sales by Application (2024-2029)
5.1.3 Global Brexpiprazole Sales Market Share by Application (2018-2029)
5.2 Global Brexpiprazole Revenue by Application (2018-2029)
5.2.1 Global Brexpiprazole Revenue by Application (2018-2023)
5.2.2 Global Brexpiprazole Revenue by Application (2024-2029)
5.2.3 Global Brexpiprazole Revenue Market Share by Application (2018-2029)
5.3 Global Brexpiprazole Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Intas Pharma
6.1.1 Intas Pharma Corporation Information
6.1.2 Intas Pharma Description and Business Overview
6.1.3 Intas Pharma Brexpiprazole Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Intas Pharma Brexpiprazole Product Portfolio
6.1.5 Intas Pharma Recent Developments/Updates
6.2 Zydus Lifesciences
6.2.1 Zydus Lifesciences Corporation Information
6.2.2 Zydus Lifesciences Description and Business Overview
6.2.3 Zydus Lifesciences Brexpiprazole Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Zydus Lifesciences Brexpiprazole Product Portfolio
6.2.5 Zydus Lifesciences Recent Developments/Updates
6.3 Ajanta Pharma
6.3.1 Ajanta Pharma Corporation Information
6.3.2 Ajanta Pharma Description and Business Overview
6.3.3 Ajanta Pharma Brexpiprazole Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ajanta Pharma Brexpiprazole Product Portfolio
6.3.5 Ajanta Pharma Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Brexpiprazole Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Brexpiprazole Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Corporation Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Brexpiprazole Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sandoz Brexpiprazole Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Otsuka Pharma
6.6.1 Otsuka Pharma Corporation Information
6.6.2 Otsuka Pharma Description and Business Overview
6.6.3 Otsuka Pharma Brexpiprazole Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Otsuka Pharma Brexpiprazole Product Portfolio
6.6.5 Otsuka Pharma Recent Developments/Updates
6.7 Lundbeck
6.6.1 Lundbeck Corporation Information
6.6.2 Lundbeck Description and Business Overview
6.6.3 Lundbeck Brexpiprazole Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lundbeck Brexpiprazole Product Portfolio
6.7.5 Lundbeck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Brexpiprazole Industry Chain Analysis
7.2 Brexpiprazole Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Brexpiprazole Production Mode & Process
7.4 Brexpiprazole Sales and Marketing
7.4.1 Brexpiprazole Sales Channels
7.4.2 Brexpiprazole Distributors
7.5 Brexpiprazole Customers
8 Brexpiprazole Market Dynamics
8.1 Brexpiprazole Industry Trends
8.2 Brexpiprazole Market Drivers
8.3 Brexpiprazole Market Challenges
8.4 Brexpiprazole Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
